ARENA PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)

bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549 

 

FORM 8-K
 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): January 13, 2020
 
Arena Pharmaceuticals, Inc.
(Exact name of Registrant as Specified in Its Charter) 

 

 
 Share
        

                                            © Acquiremedia - 2020
                                                

                        Latest news about Arena Pharmaceuticals                    

                            Longboard Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Executes into Second Amendment to That Certain License Agreement

                        

    19/09/22

                                    CI
                        

                            Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Biotechnology Select Industry Index

                        

    15/03/22

                                    CI
                        

                            Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P TMI Index

                        

    15/03/22

                                    CI
                        

                            Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Global BMI Index

                        

    15/03/22

                                    CI
                        

                            Pfizer Completes $6.7 Billion Acquisition of Arena Pharmaceuticals

                        

    11/03/22

                                    MT
                        

                            Arena Pharmaceuticals, Inc. Announces Board Changes

                        

    11/03/22

                                    CI
                        

                            Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Biotechnology Index

                        

    11/03/22

                                    CI
                        

                            Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Composite Index

                        

    11/03/22

                                    CI
                        

                            Pfizer Inc. completed the acquisition of Arena Pharmaceuticals, Inc..

                        

    10/03/22

                                    CI
                        

                            Arena Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021

                        

    23/02/22

                                    CI
                        

                            Arena Pharmaceuticals Extends Q4 Loss, Reports Higher Revenue

                        

    23/02/22

                                    MT
                        

                            Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Revenue $54,000, vs. Street Est of $0.732M

                        

    23/02/22

                                    MT
                        

                            Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Loss $-2.54, vs. Street Est of $-2.23

                        

    23/02/22

                                    MT
                        

                            Arena Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021

                        

    23/02/22

                                    CI
                        

                            Avalo Therapeutics Promotes Neil to Chief Executive, Sullivan to Finance Chief

                        

    17/02/22

                                    MT
                        

                            North American Morning Briefing : Stock Futures -3-

                        

    11/02/22

                                    DJ
                        

                            North American Morning Briefing : Bonds Yields -3-

                        

    10/02/22

                                    DJ
                        

                                HC Wainwright Downgrades Arena Pharmaceuticals to Neutral From Buy; Price Target is $100

                        

    09/02/22

                                    MT
                        

                            Transcript : Arena Pharmaceuticals, Inc. - Shareholder/Analyst Call

                        

    02/02/22

                            North American Morning Briefing : Dow Futures Dip -2-

                        

    22/12/21

                                    DJ
                        

                                Cantor Fitzgerald Downgrades Arena Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $100 From $93

                        

    21/12/21

                                    MT
                        

                            PUMP / DUMP #15 : The week's gainers and losers

                        

    17/12/21

                            North American Morning Briefing :Stocks Seen on Hold as Fed Looms

                        

    15/12/21

                                    DJ
                        

                            Arena's PT Hiked to $100 by RBC in Line With Pfizer's Proposed Bid; Downgraded to Sector Perform as no Deal Hurdles Seen

                        

    14/12/21

                                    MT
                        

                                Citigroup Downgrades Arena Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $100 From $101

                        

    14/12/21

                                    MT